drugset / Trial / NCT00909844

Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study

NCT00909844

Phase 3 Completed 35 enrolled Ipsen
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the protocol is to assess the efficacy of triptorelin 11.25 mg with respect to the proportion of children who maintain a regression or stabilisation of sexual maturity until the end of the study.

Timeline

Start
2008-04
Primary completion
2015-04
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptorelin Other / unclassified 11.25 mg

Indications